GHTM

Global Health and Tropical Medicine

  • GHTM
    • Vision
    • Mission
    • Governance
    • Scientific Advisory Board
  • News
    • Outreach
    • Events
      • GHTM Sessions
      • Workshops
    • Articles
    • Jobs
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases and pathogens
      • IHC – Individual health care
    • Research in numbers
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases and pathogens
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Technical / administrative support
  • Publications
  • Education
    • Master Theses
    • PhD Theses
  • Services
Home / Perfis / Miguel Lanaspa
  • +351 213 652 600
  • +351 213 632 105
  • Download CV
  • Orcid
  • NOVA Research

Miguel Lanaspa

Researcher

Grupo GHTM: GHTM former members

ResearchTop 5 Publications

As a pediatrician with a strong clinical research background in tropical settings, my research interest is focused on infectious diseases with high mortality burden on pediatric populations, particularly malaria and respiratory infections. My research activities aim at determining the healthy respiratory microbiome in children as a key step to design preventive tools against pediatric pneumonia, and at designing a birth cohort in a tropical setting to obtain a comprehensive picture of early-life and first years determinants of pediatric health outcomes.

  1. Lanaspa M, Bassat Q, Medeiros MM, Munoz-Almagro C. Respiratory microbiota and lower respiratory tract disease. Expert review of anti-infective therapy 2017; 15(7): 703-11.
  2. Silterra J, Gillette MA, Lanaspa M, et al. Transcriptional Categorization of the Etiology of Pneumonia Syndrome in Pediatric Patients in Malaria-Endemic Areas. J Infect Dis 2017; 215(2): 312-20.
  3. Valim C, Ahmad R, Lanaspa M, et al. Responses to Bacteria, Virus and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia. American journal of respiratory and critical care medicine 2015.
  4. Lanaspa M, O’Callaghan-Gordo C, Machevo S, et al. High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children <5 years of age admitted to hospital with clinical severe pneumonia. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2015; 21(11): 1018 e9- e15.
  5. RTS,S CTP, Agnandji ST, Lell B, et al. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. The New England journal of medicine 2012; 367(24): 2284-95.

About GHTM

GHTM is a R&D Center that brings together researchers from IHMT with a track record in Tropical Medicine and International/Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal
+351 213 652 600
+351 213 632 105

  • Facebook
  • YouTube

Subscribe Newsletter

  • How to get to GHTM/IHMT
  • GHTM Sessions
  • Research Groups
  • Cross-cutting issues
© Copyright 2023 IHMT-UNL Todos os Direitos Reservados.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    Project UID/Multi/04413/2013